TP53 and B-cell non-Hodgkin lymphoma: Wang J, Shang Z, Wang J, et al. MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.